Imclone systems (IMCL) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Imclone systems (IMCL)

IMCL 0.159

0.0%

Oct 5 5:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: tom pope who wrote (2513)	8/5/2008 8:33:50 AM
From: DewDiligence_on_SI	of 2515

Feuerstein had some encouraging things to day about YMI some time (at least a year) ago when it was around 1.90 He should have known better. How the heck can a drug purportedly using the same MoA as Erbitux have robust efficacy while not exhibiting the EGFr mechanistic side effect of rash? The answer, evidently, is that it can’t. YMI is a scam, IMHO (and I’ve been saying this on iHub for several years). The company put Lenny Saltz on the its SAB, hoping this would give the drug credibility and it actually worked—for a time. What few investors seem to realize is that Saltz never expressed the opinion that Nimo works; rather, Saltz said it would be wonderful to have another drug in the CRC armamentarium and hence he’d be available for advice (which is what an SAB is supposed to be for).

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next